FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Nuvoco IPO and Windlas Biotech IPO.
Nuvoco IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Nuvoco IPO | Windlas Biotech IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Hsbc Securities & Capital Markets Pvt Ltd ICICI Securities Limited J.P. Morgan India Private Limited SBI Capital Markets Limited |
Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Iifl Securities Ltd SBI Capital Markets Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Nuvoco IPO is up to ₹5,000.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Nuvoco IPO is ₹570.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
Nuvoco IPO | Windlas Biotech IPO | |
---|---|---|
Face Value | ₹10 per share | ₹5 per share |
Issue Price (Lower) | ₹560.00 per share | ₹448.00 per share |
Issue Price (Upper) | ₹570.00 per share | ₹460.00 per share |
Issue Price (Final) | ₹570.00 per share | ₹460.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 26 shares | 30 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹1,500.00 Cr | up to ₹165.00 Cr |
OFS Issue Size | 51,42,067 shares | |
OFS Issue Size (Amount) | up to ₹3,500.00 Cr | up to ₹236.54 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹5,000.00 Cr | up to ₹401.54 Cr |
Nuvoco IPO opens on Aug 09, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Nuvoco IPO and Windlas Biotech IPO is Aug 11, 2021, and Aug 06, 2021, respectively.
Nuvoco IPO | Windlas Biotech IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 09, 2021 | Aug 04, 2021 |
Issue Close | Aug 11, 2021 | Aug 06, 2021 |
Basis Of Allotment (Tentative) | Aug 17, 2021 | Aug 11, 2021 |
Initiation of Refunds (Tentative) | Aug 18, 2021 | Aug 12, 2021 |
Credit of Share (Tentative) | Aug 20, 2021 | Aug 13, 2021 |
Listing date (Tentative) | Aug 23, 2021 | Aug 16, 2021 |
Anchor Lockin End date 1 | Sep 16, 2021 | Sep 10, 2021 |
Anchor Lockin End date 2 | Nov 15, 2021 | Nov 09, 2021 |
Nuvoco IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
Nuvoco IPO | Windlas Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 95.24% | 78% | ||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 71.03% | 65.16% | ||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Nuvoco IPO retail investors (RII) are offered 3,12,50,000 shares while in Windlas Biotech IPO retail investors are offered 3,12,50,000 shares. Qualified institutional buyers (QIB) are offered 1,78,57,143 shares in Nuvoco IPO and 17,23,700 shares in Windlas Biotech IPO.
Nuvoco IPO | Windlas Biotech IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 1,78,57,143 shares | 17,23,700 shares |
NII | 1,33,92,858 shares | 13,23,766 shares |
RII | 3,12,50,000 shares | 30,88,786 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 6,25,00,001 shares | 61,36,252 shares |
Nuvoco IPO subscribed 1.71x in total, whereas Windlas Biotech IPO subscribed 22.44x.
Nuvoco IPO | Windlas Biotech IPO | |
---|---|---|
QIB (times) | 4.23x | 24.40x |
NII (times) | 0.66x | 15.73x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.73x | 24.22x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.71x | 22.44x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|